A program to help TAVR patients recover through early mobilization
Official title: The JUMPSTART Program: Encouraging Early Mobilization and Optimizing Recovery of TAVR Patients' Post-hospital Discharge
Run by McMaster University · NCT06040398 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a new online exercise program to help patients recovering from heart valve surgery feel better and recover faster at home.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | McMaster University Academic / other |
| Locations | 1 site (Hamilton, Ontario) |
| Trial ID | NCT06040398 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are outpatients who have undergone a TAVR procedure and successfully completed a pre-discharge ambulation assessment.
✕Probably not a fit
Patients who are hospitalized after the procedure or have specific complications, such as those requiring a pacemaker, may not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The JUMPSTART program is a virtual, self-directed early mobilization initiative designed for patients recovering from Transcatheter Aortic Valve Replacement (TAVR) at Hamilton General Hospital. It includes a series of exercise videos tailored to varying levels of intensity, allowing patients to engage in rehabilitation from home after discharge. The program aims to enhance recovery by optimizing participation and evaluating outcomes through follow-up surveys and administrative data. Eligible patients will be introduced to the program during their pre-TAVR clinic visit and can choose to participate in the research aspect of the program.
Why it matters
Potential benefit: If successful, this program could significantly improve the recovery and quality of life for TAVR patients post-discharge.
How similar studies have gone: Similar approaches in early mobilization programs have shown promise in improving recovery outcomes, suggesting potential success for this initiative.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Outpatients who have undergone a TAVR procedure at the Hamilton General Hospital * Patients who are managed through the overnight-model pathway * Patients who successfully completed ambulation assessment * Patients who are deemed eligible for discharge Exclusion Criteria: * Patients who are hospitalized after the procedure (inpatients) * Patients who had an axillary approach for TAVR * Patients who had a pacemaker temporarily left in at the end of case, and * Patients who received a permanent pacemaker in the last month
Where it's running
-
Hamilton Health Sciences (McMaster Children's Hospital and Hamilton General Hospital)
Hamilton, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Madhu K Natarajan, MD — Hamilton Health Sciences and McMaster University
- Study coordinator: Marija Corovic, MPH
- Email: corovicm@mcmaster.ca
- Phone: (905) 525-9140
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluation of the Point-Guard device during heart valve replacement
This study is testing a new device called Point-Guard to see if it can help prevent brain problems during heart valve replacement surgery.
-
Evaluating the SAPIEN 3 Ultra RESILIA Valve for Aortic Stenosis
This study tests how well the new SAPIEN 3 Ultra RESILIA valve works for people with severe aortic stenosis who are getting a heart valve replacement, by checking its performance over the next 10 years.
-
Assessing ischemic and bleeding risks after TAVR
This study looks at the risks of bleeding and heart problems in patients getting a new heart valve through TAVR to see how to best tailor their blood-thinning treatment.
-
Evaluating coronary re-engagement after TAVR with a Navitor valve
This study is testing if a new way of placing a heart valve during TAVR can help doctors still access the coronary arteries for patients who have both aortic stenosis and coronary artery disease.
-
Transcatheter Aortic Valve Replacement Registry for Outcomes and Quality Monitoring
This registry collects information from hospitals about patients undergoing TAVR to see how care and outcomes compare to guidelines and nationwide data.
-
SYMmetric Valve expansion to reduce hypoattenuated leaflet thickening after balloon-expandable TAVI
This trial tests whether the Double-TAP post-dilatation strategy can reduce HALT and improve valve function in patients 70 or older undergoing balloon-expandable TAVI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.